Quest Diagnostics Incorporated (DGX) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	11.6B	11.0B	9.9B	9.3B	9.9B
Cost of Revenue	7.7B	7.5B	6.6B	6.2B	6.5B
Gross Profit	3.8B	3.5B	3.2B	3.1B	3.4B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	2.0B	2.0B	1.8B	1.6B	1.9B
General & Admin Expense	504.0M	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	177.0M	(47.0M)	128.0M	192.0M	131.0M
Total Operating Expenses	2.2B	1.9B	1.9B	1.8B	2.0B
Cost and Expenses	9.9B	9.4B	8.5B	8.0B	8.5B
Operating Income (EBIT)	1.6B	1.6B	1.3B	1.3B	1.4B
Non-Operating
Interest Income	6.0M	13.0M	25.0M	11.0M	10.0M
Interest Expense	262.0M	277.0M	226.0M	163.0M	148.0M
Net Interest Income	(256.0M)	(264.0M)	(201.0M)	(152.0M)	(138.0M)
Other Non-Op Income/Expense	(216.0M)	(243.0M)	(152.0M)	(106.0M)	(149.0M)
Non-Operating Income (excl Interest)	(11.0M)	(21.0M)	(55.0M)	(31.0M)	45.0M
EBT (Pre-Tax Income)	1.4B	1.4B	1.2B	1.2B	1.3B
Income Tax Expense	320.0M	314.0M	273.0M	248.0M	264.0M
Bottom Line
Net Income	1.1B	992.0M	871.0M	854.0M	946.0M
Earnings from Cont. Ops	1.1B	1.0B	921.0M	908.0M	1.0B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	1.1B	992.0M	866.0M	850.0M	942.0M
Per Share
Basic EPS	$9.54	$8.87	$7.80	$7.59	$8.12
Diluted EPS	$9.42	$8.75	$7.69	$7.52	$7.98
Revenue Per Share	$105.09	$99.41	$88.94	$82.61	$85.20
Shares
Basic Shares Outstanding	110.0M	111.0M	111.0M	112.0M	116.0M
Diluted Shares Outstanding	112.0M	113.0M	113.0M	113.0M	118.0M
Profitability Metrics
EBITDA	2.0B	2.2B	1.9B	1.7B	1.8B
D&A	362.0M	570.0M	493.0M	439.0M	437.0M
EBIT	1.6B	1.6B	1.4B	1.3B	1.4B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026